79 related articles for article (PubMed ID: 11372692)
1. Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife.
Huhle G; Liebe V; Hudek R; Heene DL
Thromb Haemost; 2001 May; 85(5):936-8. PubMed ID: 11372692
[No Abstract] [Full Text] [Related]
2. Interference of thrombin in immunological assays for hirudin specific antibodies.
Hamilton RG; Levy JH; Marder VJ; Sane DC
J Immunol Methods; 2012 Jul; 381(1-2):50-8. PubMed ID: 22542931
[TBL] [Abstract][Full Text] [Related]
3. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
[TBL] [Abstract][Full Text] [Related]
4. Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.
Song X; Huhle G; Wang L; Hoffmann U; Harenberg J
Circulation; 1999 Oct; 100(14):1528-32. PubMed ID: 10510056
[TBL] [Abstract][Full Text] [Related]
5. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
[TBL] [Abstract][Full Text] [Related]
6. Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
Warkentin TE
Best Pract Res Clin Haematol; 2004 Mar; 17(1):105-25. PubMed ID: 15171961
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular drug highlight: hirudin.
Cheng-Lai A
Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
[TBL] [Abstract][Full Text] [Related]
8. The direct thrombin inhibitor hirudin.
Greinacher A; Warkentin TE
Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
[TBL] [Abstract][Full Text] [Related]
9. Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin.
Fischer KG; Liebe V; Hudek R; Piazolo L; Haase KK; Borggrefe M; Huhle G
Thromb Haemost; 2003 Jun; 89(6):973-82. PubMed ID: 12783109
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of recombinant hirudin.
Nowak G
Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
[TBL] [Abstract][Full Text] [Related]
11. [Rapid determination of contents of hirudin's hydrolysates in processed leech by dot blotting].
Wang HW; Tian JZ
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2193-5. PubMed ID: 19166004
[TBL] [Abstract][Full Text] [Related]
12. Hirudin treatment in a breastfeeding woman.
Lindhoff-Last E; Willeke A; Thalhammer C; Nowak G; Bauersachs R
Lancet; 2000 Feb; 355(9202):467-8. PubMed ID: 10841132
[TBL] [Abstract][Full Text] [Related]
13. Desirudin (Iprivask) for DVT prevention.
Med Lett Drugs Ther; 2010 Nov; 52(1350):85-6. PubMed ID: 21045759
[No Abstract] [Full Text] [Related]
14. [Management of HIT II patients with hirudin antibodies after primary therapy].
Harenberg J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37 Suppl 1():S8-11. PubMed ID: 11973671
[No Abstract] [Full Text] [Related]
15. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
Zhang YJ; Wang XL; Wu JM; Cheng MX
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):801-4. PubMed ID: 17639978
[TBL] [Abstract][Full Text] [Related]
16. Hirudin determination in plasma can be strongly influenced by the prothrombin level.
Lindhoff-Last E; Piechottka GP; Rabe F; Bauersachs R
Thromb Res; 2000 Oct; 100(1):55-60. PubMed ID: 11053617
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of rec-hirudin in healthy volunteers after intravenous administration.
Cardot JM; Lefèvre GY; Godbillon JA
J Pharmacokinet Biopharm; 1994 Apr; 22(2):147-56. PubMed ID: 7815310
[TBL] [Abstract][Full Text] [Related]
18. Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.
Greinacher A; Eichler P; Albrecht D; Strobel U; Pötzsch B; Eriksson BI
Blood; 2003 Apr; 101(7):2617-9. PubMed ID: 12393696
[TBL] [Abstract][Full Text] [Related]
19. Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin.
Carr CS; Rayner A; Ponte J; Desai JB
Ann Thorac Surg; 2005 Feb; 79(2):696-8. PubMed ID: 15680867
[TBL] [Abstract][Full Text] [Related]
20. Studies for revealing a possible sensitization to hirudin after repeated intravenous injections in baboons.
Bichler J; Gemmerli R; Fritz H
Thromb Res; 1991 Jan; 61(1):39-51. PubMed ID: 1708530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
